Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Minghui Pharmaceutical clinical trials
The registry lists 25 studies whose lead sponsor is Minghui Pharmaceutical or one of 2 companies grouped under it. 16 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.
Get an email when these change. Save the Minghui Pharmaceutical studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Minghui Pharmaceutical.
- Minghui Pharmaceutical (Hangzhou) Ltd20 studies →Subsidiary
Something wrong?
- Minghui Pharmaceutical Pty Ltd3 studiesSame company
Something wrong?
- Minghui Pharmaceutical (Shanghai) LTD2 studies →Subsidiary
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 25 of 25.
- A Clinical Study of MHB034C for Injection in Participants With Advanced Solid TumorsNot yet recruitingNCT07928570Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Shanghai) LTD
- Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled StudyRecruitingNCT07622108Phase 3
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- Treatment of Chronic Thyroid Eye Disease With MHB018ARecruitingNCT07622121Phase 3
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB046C Injection in Patients With Advanced Solid TumorsRecruitingNCT06985355Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB118C Injection in Patients With Advanced Solid TumorsRecruitingNCT07045454Phase 1
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid TumorsRecruitingNCT07126665Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid TumorsRecruitingNCT07130383Phase 2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental VitiligoRecruitingNCT07682506Phase 3
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- Open-Label Extension Study of MHB018A in Patients With Thyroid Eye DiseaseNot yet recruitingNCT07620405Phase 3
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB009C in Patients With Advanced Solid TumorsRecruitingNCT07326488Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB042C in Patients With Advanced Solid TumorsRecruitingNCT07192107Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB048C in Patients With Advanced Solid TumorsRecruitingNCT07192120Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye DiseaseRecruitingNCT07262476Phase 3
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung CancerRecruitingNCT07229599Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- Study of MHB088C in Participants With Advanced or Metastatic Solid TumorsNot yet recruitingNCT05652855Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical Pty Ltd
- Study of MHB036C in Participants With Advanced or Metastatic Solid TumorsNot yet recruitingNCT05642949Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical Pty Ltd
- A Study of MHB036C for Advanced Solid TumorActive, not recruitingNCT06373406Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- MHB018A Treatment in Patients With Active Thyroid Eye DiseaseActive, not recruitingNCT06989918Phase 3
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- MHB018A Treatment in Patients With Chronic Thyroid Eye DiseaseActive, not recruitingNCT07257185Phase 3
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental VitiligoCompletedNCT07181187Phase 2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Study of MHB039A for Advanced Solid TumorActive, not recruitingNCT06345482Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic DermatitisCompletedNCT07185282Phase 3
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic DermatitisCompletedNCT07182864Phase 1/2
Sponsor listed in the registry: Minghui Pharmaceutical (Hangzhou) Ltd
- This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell MalignanciesStatus unknownNCT04689308Phase 1
Sponsor listed in the registry: Minghui Pharmaceutical (Shanghai) LTD
- MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid ArthritisStatus unknownNCT04815148Phase 1
Sponsor listed in the registry: Minghui Pharmaceutical Pty Ltd